Filing Flows

Filing Flows › Core Laboratories (CLB) › Q1 2025

Core Laboratories (CLB) Q1 2025 earnings results (first quarter 2025)

10-Q filed Apr 28, 2025

Core Laboratories (CLB) reported revenue of $124M for the first quarter 2025 (Q1 2025), -5% from a year earlier and -4% from the quarter before. Operating margin was 3.6%, net earnings $69K (0.1% of revenue).

Revenue$124M
Year over year-5%
Quarter over quarter-4%
Operating margin3.6%
Net earnings$69K

Core Laboratories, Q1 2025: revenue $124M (-5% year over year), operating margin 3.6%, net earnings $69K, operating cash flow $6.7M. The chart follows the revenue to costs, profit and cash.

Q1 2025AmountQ/QY/Y
Revenue$124M-4%-5%
Operating profit$4.4M-69%-48%
Net earnings$69K-99%-98%
Operating cash flow$6.7M-68%+20%
Free cash flow$3.9M——

What changed

Revenue was $123.6M in Q1 2025, down 5% year over year and down 4% from the previous quarter. Service was the largest line at 77% of revenue. Product lost $4.6M year over year (down 14%), 77% of the total change.

Operating profit was $4.4M, a 3.6% margin (down 3.0 points year over year). Total costs fell 2% while revenue fell 5%. The fastest-growing cost line was Other operating costs (+29%). Net earnings were −$154K. The effective tax rate was 96.2%.

Operating cash flow was $6.7M (up 20% year over year), 9652% of net income including minority interests. Non-cash charges added back $3.7M of depreciation and amortization and $4.2M of share-based compensation. Working capital and other items used $1.3M. After capital expenditures - operations ($2.8M), free cash flow as the company reports it was $3.9M.

Questions

What was Core Laboratories' revenue in the first quarter 2025?

Core Laboratories (CLB) reported revenue of $124M for the first quarter 2025 (Q1 2025), -5% from a year earlier and -4% from the quarter before.

Was Core Laboratories profitable in the first quarter 2025?

Operating profit was $4.4M (3.6% of revenue) and net earnings $69K.

Open the interactive Sankey →

Source: Core Laboratories 10-Q on SEC EDGAR.